Price T Rowe Associates Inc Bio N Tech Se Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Bio N Tech Se stock. As of the latest transaction made, Price T Rowe Associates Inc holds 318,869 shares of BNTX stock, worth $32.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

318,869

Previous 52,202 510.84%

Holding current value

$32.6 Million

Previous $4.2 Million 802.81%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$78.36 - $124.66 $20.9 Million - $33.2 Million	266,667 Added 510.84%	318,869 $37.9 Million
Q2 2024 Aug 14, 2024	SELL	$80.36 - $102.87 $31,581 - $40,427	-393 Reduced 0.75%	52,202 $4.2 Million
Q1 2024 May 15, 2024	SELL	$88.96 - $112.35 $850,635 - $1.07 Million	-9,562 Reduced 15.38%	52,595 $4.85 Million
Q4 2023 Feb 14, 2024	BUY	$90.91 - $112.75 $140,365 - $174,086	1,544 Added 2.55%	62,157 $6.56 Million
Q2 2023 Aug 14, 2023	SELL	$102.58 - $129.66 $30,774 - $38,898	-300 Reduced 0.49%	60,613 $6.54 Million
Q1 2023 May 15, 2023	SELL	$122.57 - $153.67 $88.7 Million - $111 Million	-723,365 Reduced 92.23%	60,913 $7.59 Million
Q4 2022 Feb 14, 2023	SELL	$118.43 - $186.05 $55.9 Million - $87.8 Million	-472,031 Reduced 37.57%	784,278 $118 Million
Q3 2022 Nov 14, 2022	SELL	$127.65 - $183.11 $75.5 Million - $108 Million	-591,626 Reduced 32.02%	1,256,309 $169 Million
Q2 2022 Aug 15, 2022	BUY	$123.25 - $186.24 $39.6 Million - $59.8 Million	321,110 Added 21.03%	1,847,935 $276 Million
Q1 2022 May 16, 2022	SELL	$126.25 - $231.85 $1.38 Million - $2.53 Million	-10,898 Reduced 0.71%	1,526,825 $260 Million
Q4 2021 Feb 14, 2022	BUY	$216.64 - $362.52 $81 Million - $136 Million	373,884 Added 32.13%	1,537,723 $396 Million
Q3 2021 Nov 15, 2021	SELL	$205.93 - $447.23 $179 Million - $388 Million	-866,822 Reduced 42.69%	1,163,839 $318 Million
Q2 2021 Aug 16, 2021	SELL	$113.32 - $241.49 $5.01 Million - $10.7 Million	-44,245 Reduced 2.13%	2,030,661 $455 Million
Q1 2021 May 17, 2021	BUY	$85.73 - $119.5 $42.9 Million - $59.8 Million	500,085 Added 31.76%	2,074,906 $227 Million
Q4 2020 Feb 16, 2021	BUY	$72.71 - $129.54 $115 Million - $204 Million	1,574,821 New	1,574,821 $128 Million

Others Institutions Holding BNTX

# of Institutions

356

Shares Held

38.3M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $24.8B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Bio N Tech Se Transaction History